Caldwell Sutter Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Caldwell Sutter Capital's BMY Position: Q2 2026 in Review
Caldwell Sutter Capital increased its Bristol-Myers Squibb (BMY) stake by 0.1% in Q2 2026, buying an estimated $402 and bringing the position to 7,036 shares worth $405K. The position accounts for 0.15% of the portfolio, ranked #150.
Caldwell Sutter Capital first reported a position in BMY in Q4 2022 and has held it in 15 quarters since. The position peaked at $426K in Q1 2026. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Caldwell Sutter Capital held 7,036 shares of Bristol-Myers Squibb worth $405K as of Q2 2026.
- Caldwell Sutter Capital bought 7 Bristol-Myers Squibb shares in Q2 2026, an estimated $402.
- Bristol-Myers Squibb made up 0.15% of Caldwell Sutter Capital's portfolio in Q2 2026, its #150 holding.
- Caldwell Sutter Capital first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 15 quarters since.
- Caldwell Sutter Capital's Bristol-Myers Squibb position peaked at $426K in Q1 2026.
- 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Caldwell Sutter Capital's 13F filing for Q2 2026, filed 5 Aug 2026.